AIG
DFTX

American International Group’s Definium Therapeutics DFTX Stock Holding History

American International Group’s Portfolio DFTX Stock Details DFTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-10,660
Closed -$177K – 3204
2022
Q1 		$177K Sell
10,660
-1,668
-14% -$28.9K ﹤0.01% 2311
2021
Q4 		$255K Sell
12,328
-368
-3% -$11.7K ﹤0.01% 2222
2021
Q3 		$444K Buy
12,696
+665
+6% +$28.8K ﹤0.01% 1934
2021
Q2 		$623 Buy
+12,031
New +$632K ﹤0.01% 1786

Other funds holding DFTX

Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
DCI
Data Collective IV Palo Alto, California $55.9M AUM 49.14% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
BB
Busey Bank Urbana, Illinois $3.68B AUM 26.6% 1-Year Est. Return
E
Ergoteles New York $68.2M AUM 36.16% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Swiss National Bank
Swiss National Bank Zurich, Switzerland $174B AUM 30.96% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return
AI
AdvisorShares Investments Bethesda, Maryland $549M AUM 32.58% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

American International Group's DFTX Position: Q2 2022 in Review

American International Group sold out of Definium Therapeutics (DFTX) in Q2 2022, closing a stake of 10,660 shares — an estimated $177K sold.

American International Group first reported a position in DFTX in Q2 2021 and held it in 4 quarters. The position peaked at $444K in Q3 2021. 155 funds tracked by Wall St. Rank hold DFTX as of Q2 2022.

  • American International Group reported no remaining Definium Therapeutics position as of Q2 2022 after selling out during the quarter.
  • American International Group sold 10,660 Definium Therapeutics shares in Q2 2022, an estimated $177K.
  • American International Group first reported a position in Definium Therapeutics in Q2 2021 and held it in 4 quarters.
  • American International Group's Definium Therapeutics position peaked at $444K in Q3 2021.
  • 155 funds tracked by Wall St. Rank held Definium Therapeutics as of Q2 2022.

Based on American International Group's 13F filing for Q2 2022, filed 12 Aug 2022.